Genetic epilepsies generally present in children aged 2–10 years, during the developmental phase when the neural network undergoes ‘pruning’, and often spontaneously remit. Idiopathic epilepsies are common in dogs and in some breeds are ten times more common than in humans. It was previously reported that the Lagotto romagnolo breed exhibits an epileptic disorder with onset at ∼7 weeks (equivalent to age 2 years in humans) and remit at ∼4 months (age 8 years in humans). Seppälä et al. now report the genetic defect and affected neurological pathways underlying this phenotype. Mapping studies showed that the genetic defect results in truncation of the secreted neuronal protein LGI2, preventing its secretion and interaction with three ADAM-family neuronal membrane receptors. LGI2 mutations have not been associated with human epilepsy, but autosomal dominant lateral temporal lobe epilepsy (ADLTE) is associated with mutations in LGI1, which interacts with the same ADAM-family receptors. These interactions are thought to stabilize synapses, and LGI1 seems to protect the brain against seizures during and/or after the pruning phase. By contrast, the authors propose, based on LGI gene expression data, that LGI2 might be important for preventing seizures early during development of the neural network, before pruning. These results suggest that LGI2 should be considered as a candidate gene in childhood epilepsies.
Understanding epilepsy in a canine model
Understanding epilepsy in a canine model. Dis Model Mech 1 September 2011; 4 (5): 558. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2024: Pre-clinical Modelling of Human Genetic Disease and Therapy

Registration is now open for our 2024 Journal Meeting. Rapid advances in gene editing and genetic technologies have revolutionised our ability to model human genetic disease and provided new hope for gene therapies. At this Meeting, we will present the very latest advances in modelling human genetic disease.
Moving towards heart success – Disease Models & Mechanisms Special Issue

DMM's most recent special issue compiles articles that aim to move heart failure to heart success by fundamentally addressing the roots of failure to identify curative strategies.
Crossroads in Virology

Our October Editorial written by Sumana Sanyal emphasises the urgency of a concerted effort in understanding virus–host interactions to inform the development of therapeutics and vaccines, helping to predict disease outcomes. Read the full Editorial here.
A Model for Life - an interview with Professor Kiran Musunuru




Read our new A Model for Life interview with Kiran Musunuru. Prof Musunuru investigates the mechanisms of disease in model systems, with the ultimate goal of developing innovative gene editing therapies.
Sustainable Conferencing Initiative

Through our Sustainable Conferencing Grants, we promote the use of new technology and greener modes of travel. Our blog posts showcase examples of sustainability in action and share experience about how new technologies and conference formats work in practice.
Other journals from
The Company of Biologists